Watt Test and VO2 Max in Women: How Sex Hormones and Your Cycle Change Everything
At a glance
- What it measures / peak oxygen uptake during maximal exercise (mL/kg/min)
- Gold-standard method / direct VO2 max test (metabolic cart) or Watt-based ramp protocol
- Women's "good" range age 20-29 / 35-43 mL/kg/min (ACSM percentile data)
- Women's "good" range age 50-59 / 26-33 mL/kg/min (ACSM percentile data)
- Longevity threshold / each 1 mL/kg/min increase linked to ~9% lower cardiovascular mortality
- Menstrual cycle effect / VO2 max may be 3-5% higher in the follicular phase
- Perimenopause decline / women lose roughly 1% per year after age 40 without intervention
- Pregnancy note / VO2 max (mL/kg/min) drops in late pregnancy due to weight gain; absolute oxygen uptake rises
- Exercise safety in pregnancy / cleared by ACOG with physician guidance
- Best longevity target for women / above the 75th percentile for your age group
What the Watt Test Actually Measures, and Why Women Need Sex-Specific Numbers
The Watt test is a graded exercise protocol in which power output (watts) increases every minute until you cannot continue. A metabolic cart captures the oxygen consumed at each stage. The highest recorded oxygen consumption before failure is your VO2 max, expressed in milliliters of oxygen per kilogram of body weight per minute.
Most VO2 max reference charts published before 2010 were built predominantly on male subjects. The American College of Sports Medicine's ACSM's Guidelines for Exercise Testing and Prescription does provide sex-stratified tables, but even those tables are population averages that collapse meaningful within-sex variation driven by hormonal status.
Women's physiology differs from men's in ways that directly alter VO2 max:
- Lower hemoglobin concentration. Premenopausal women carry roughly 12-16 g/dL hemoglobin versus 14-18 g/dL in men, reducing oxygen-carrying capacity per liter of blood.
- Smaller heart chambers. Left ventricular volume averages 15-20% smaller in women, limiting stroke volume and therefore cardiac output at maximal effort.
- Higher body-fat percentage at equivalent fitness. Because VO2 max is divided by total body mass, a woman with greater fat mass at the same lean fitness level scores lower on the per-kilogram metric.
- Estrogen-mediated substrate differences. Estrogen shifts fuel use toward fat oxidation and away from glycogen, which has downstream effects on lactate threshold and submaximal performance.
These differences are not deficits. They are biology. Comparing a woman's VO2 max to a male reference range and concluding she is "less fit" is a measurement error, not a clinical finding.
Women's VO2 Max Reference Ranges by Age
ACSM Percentile-Based Norms
The ACSM percentile norms for women stratify cardiorespiratory fitness into five categories. The table below shows the "good" (60th-79th percentile) range for each decade.
| Age group | Low (<25th %ile) | Fair (25th-44th) | Good (60th-79th) | Excellent (>80th) | |-----------|---------------------|-------------------|------------------|----------------------| | 20-29 | <32 | 32-36 | 37-43 | >43 | | 30-39 | <29 | 29-33 | 34-39 | >39 | | 40-49 | <26 | 26-30 | 31-36 | >36 | | 50-59 | <23 | 23-27 | 28-33 | >33 | | 60-69 | <20 | 20-24 | 25-30 | >30 |
All values in mL/kg/min.
The Longevity Threshold That Changes the Clinical Conversation
A 2018 analysis of 122,007 patients in JAMA Network Open found that cardiorespiratory fitness was a stronger predictor of all-cause mortality than hypertension, diabetes, smoking, or cardiovascular disease. Moving from "low" to "below average" fitness reduced mortality risk by 50%. Moving from "high" to "elite" reduced it by a further 23%.
Critically, the survival benefit was present in women across every age decade studied. Each 1 MET increase in fitness capacity (roughly 3.5 mL/kg/min) was associated with approximately a 13% reduction in all-cause mortality risk in women.
That figure is the reason VO2 max has moved from sports-science lab to women's preventive-medicine visit.
How Your Menstrual Cycle Shifts VO2 Max
The Follicular Phase Advantage
Your menstrual phase matters more than most clinicians tell you. In the follicular phase (days 1-14, from the first day of menstruation through ovulation), rising estrogen enhances ventilatory drive, increases red-blood-cell 2,3-DPG concentration, and may improve mitochondrial efficiency. Several small trials report VO2 max values measured in the follicular phase running 3-5% above values recorded in the luteal phase.
The Luteal Phase Drop
Progesterone dominates the luteal phase (days 15-28 approximately). Progesterone stimulates ventilation at rest, raising baseline minute ventilation and the perception of breathing effort during exercise. Core body temperature rises 0.3-0.5°C. These changes can make the same absolute workload feel harder, which may cause women to terminate a maximal test earlier than they would in the follicular phase, artificially lowering the recorded VO2 max.
A 2021 systematic review in Sports Medicine of 51 studies concluded that exercise performance is most likely to be highest in the follicular phase, though the authors noted that methodological variability across studies and failure to verify ovulation with progesterone assays limits certainty.
Practical Testing Implication
If you are tracking VO2 max over time as a longevity marker, test in the same menstrual phase each time. Ideally, test in the mid-follicular phase (days 5-10) when estrogen is rising and progesterone is low. Without this consistency, a "decline" in VO2 max from one test to the next may simply reflect luteal-phase physiology rather than true fitness loss.
The WomanRx Cycle-Standardized Testing Protocol:
- Confirm cycle day and phase using a period-tracking app or progesterone-verified ovulation data.
- Schedule the Watt test for days 5-10 of your cycle.
- Record cycle day on every VO2 max result in your chart.
- Flag any result taken in the luteal phase with an asterisk before comparing to prior values.
This approach has not been formally validated in a clinical trial, but it is grounded directly in the luteal-phase physiology described above and is consistent with how elite women's sports-medicine programs approach serial fitness testing.
VO2 Max Across the Reproductive Life Stages
Reproductive Years (Ages 18-40)
Women in their reproductive years who exercise regularly can achieve VO2 max values in the 40-55 mL/kg/min range. Values above the 75th percentile for age are associated with meaningful longevity benefit and reduced risk of type 2 diabetes, metabolic syndrome, and cardiovascular disease.
PCOS deserves specific mention here. Women with PCOS have, on average, lower cardiorespiratory fitness than age-matched controls without PCOS, even after adjusting for body weight. A 2019 meta-analysis in Human Reproduction found VO2 max averaged 3.5 mL/kg/min lower in women with PCOS versus controls. Insulin resistance, higher sympathetic tone, and reduced exercise tolerance all contribute. For women with PCOS, achieving even a "fair" VO2 max range is clinically meaningful and may reduce androgen levels and improve insulin sensitivity independent of weight loss.
Trying to Conceive
Moderate-intensity aerobic exercise to maintain VO2 max does not impair fertility in most women. The ASRM notes that vigorous exercise exceeding 60 minutes daily may suppress the hypothalamic-pituitary-ovarian axis in women with low energy availability, disrupting ovulation. If you are trying to conceive and training at a high volume, tracking VO2 max alongside luteal-phase progesterone levels can help identify whether energy availability is adequate.
Pregnancy
VO2 max expressed in mL/kg/min typically falls in the third trimester. Body weight rises, and the per-kilogram denominator increases faster than absolute oxygen uptake in most pregnancies. Absolute VO2 max in liters per minute, by contrast, may actually increase slightly due to plasma volume expansion and increased cardiac output.
Formal maximal exercise testing is rarely performed in pregnancy. ACOG Practice Bulletin 650 supports moderate to vigorous intensity exercise in uncomplicated pregnancies and lists only a small number of absolute contraindications (placenta previa, preterm labor, severe preeclampsia, and a few others). Submaximal fitness estimates, such as a 6-minute walk test or heart-rate-based estimation, are preferred over maximal Watt-test protocols during pregnancy.
Postpartum and Lactation
VO2 max typically returns to pre-pregnancy baseline within 3-6 months postpartum in women who resume training. Lactation itself does not impair aerobic capacity, though moderate acute rises in breast-milk lactic acid immediately after high-intensity exercise are well-documented and transient.
ACOG supports resuming aerobic exercise gradually in the postpartum period once the woman is medically stable, with no fixed waiting period after uncomplicated vaginal delivery.
Perimenopause (Typically Ages 40-52)
This is where VO2 max decline accelerates, and it is not simply about aging. Estrogen directly supports mitochondrial function, skeletal muscle satellite-cell activity, and red-blood-cell production. As estrogen fluctuates and eventually falls during perimenopause, cardiorespiratory fitness can drop faster than age-matched predictions would suggest.
A 2020 study in Menopause found that perimenopausal women showed significantly accelerated VO2 max decline compared to premenopausal women of similar age and activity level. The authors suggested estrogen's role in mitochondrial biogenesis as a mechanistic driver.
The practical implication: if your VO2 max is dropping faster than 1 mL/kg/min per year during your mid-40s, hormonal status is a plausible contributor alongside lifestyle factors. This is worth discussing with your clinician, particularly if menopause hormone therapy is otherwise being considered.
Post-Menopause
After menopause, the average woman's VO2 max decline rate is approximately 10% per decade without intervention, which is roughly double the rate seen in premenopausal women of the same fitness level. The Women's Health Initiative showed that physical activity in postmenopausal women was associated with reduced all-cause and cardiovascular mortality, with the greatest risk reduction seen in women moving from sedentary to moderate fitness categories.
Menopausal hormone therapy (MHT) may modestly attenuate VO2 max decline. A randomized trial published in Menopause found that women on estrogen therapy showed better preservation of cardiorespiratory fitness over two years compared to placebo, though the effect size was small and exercise training independently produced larger gains than MHT alone.
How Sex Hormones Change the Physiology Directly
Estrogen
Estrogen receptors are expressed in skeletal muscle, cardiac muscle, endothelium, and mitochondrial membranes. Estrogen:
- Upregulates the expression of PGC-1alpha, the master regulator of mitochondrial biogenesis
- Reduces oxidative stress in exercising muscle
- Supports iron absorption and red-blood-cell production, both essential for oxygen delivery
- Increases nitric oxide bioavailability, improving blood-flow distribution during exercise
These mechanisms explain why VO2 max tracks so closely with estrogen status across a woman's life.
Progesterone
Progesterone's primary effect on exercise performance is through ventilatory drive. It raises resting ventilation and exaggerates the ventilatory response to CO2 during exercise. This is not harmful. In fact, the elevated ventilation may partially offset altitude-related hypoxia, which is why some researchers have proposed that women may outperform men at altitude relative to sea-level ability. The cost is a higher perceived exertion at a given absolute workload during the luteal phase.
Testosterone
Women produce 5-10% of the testosterone that men produce, primarily from the adrenal glands and ovaries. Even within the female-normal range (15-70 ng/dL), higher free testosterone is associated with better lean mass, stronger skeletal muscle, and modestly higher VO2 max. Women with primary ovarian insufficiency or surgical menopause who lose both estrogen and androgen simultaneously show the steepest fitness declines.
What Lowers VO2 Max in Women: Female-Specific Factors
Beyond aging and physical inactivity, several conditions common in women specifically reduce cardiorespiratory fitness:
- PCOS. As described above, insulin resistance and hormonal imbalance suppress aerobic capacity.
- Hypothyroidism. Thyroid hormone governs mitochondrial respiration rate. Even subclinical hypothyroidism (TSH above 2.5 mIU/L in some definitions) can reduce VO2 max. Testing thyroid function is warranted when VO2 max is unexpectedly low.
- Iron deficiency anemia. One of the most common and correctable causes of low VO2 max in premenopausal women. Iron deficiency without frank anemia (ferritin <30 ng/mL) can reduce maximal oxygen delivery meaningfully.
- Disordered eating and low energy availability. Relative energy deficiency in sport (RED-S) suppresses EPO production, reduces plasma volume, and impairs mitochondrial adaptation to training.
- Depression and anxiety. Associated with autonomic dysregulation and lower exercise tolerance independent of physical activity level.
- Sleep apnea. Underdiagnosed in women (who often present without classic snoring), sleep apnea causes chronic hypoxemia and blunts training adaptations.
How to Improve VO2 Max: What the Evidence Says for Women
High-Intensity Interval Training
HIIT is the most evidence-supported method for improving VO2 max in women. A meta-analysis in the British Journal of Sports Medicine found HIIT produced 1.5 times greater VO2 max gains than moderate-intensity continuous training in women. A typical effective protocol: 4 x 4-minute intervals at 85-95% of maximum heart rate, three times per week.
Cycle timing may enhance HIIT response. Scheduling high-intensity sessions in the follicular phase, when estrogen supports faster muscle repair, may allow greater training density and better adaptation. This is extrapolated from the physiology rather than directly studied in large randomized trials.
Zone 2 Training
Zone 2 cardio (60-70% of maximum heart rate, the pace where you can hold a conversation) drives mitochondrial biogenesis over weeks to months. Women respond to Zone 2 with strong increases in fat oxidation capacity and lactate threshold. Three to five hours of Zone 2 per week is the target used in most longevity-medicine protocols, though the optimal dose for women specifically has not been established in a dedicated RCT.
Strength Training as a Complementary Tool
Lean muscle mass directly supports VO2 max by increasing the metabolic machinery available to consume oxygen. Resistance training twice per week is now recommended alongside aerobic training for cardiorespiratory fitness preservation in women over 40.
Who Should Prioritize VO2 Max Testing
VO2 max testing is most valuable in these female-specific scenarios:
Higher priority:
- Women over 45 who want a quantified longevity baseline
- Women with PCOS, type 2 diabetes, or metabolic syndrome
- Perimenopausal women experiencing unexplained fatigue or reduced exercise tolerance
- Postmenopausal women with cardiovascular risk factors
- Women with a family history of early cardiovascular disease
- Women on thyroid medication wanting to verify fitness impact
Lower priority (testing adds less at baseline):
- Active women under 35 with no risk factors and consistent training
- Women in the first trimester of pregnancy (defer until postpartum)
- Women currently in the luteal phase who want a one-time "baseline" (wait for follicular phase)
Pregnancy and Lactation: What You Need to Know
This article covers a fitness test, not a drug, so there is no pregnancy contraindication in the classic pharmacological sense. The clinical considerations are practical:
Maximal-effort Watt-test protocols are not recommended during pregnancy. The test requires pushing to exhaustion, which carries theoretical risk of excessive maternal heart rate, hypotension, and reduced uterine blood flow. ACOG recommends keeping maternal heart rate within monitored limits and avoiding supine exercise after the first trimester.
Submaximal fitness estimations are appropriate during uncomplicated pregnancy. The Rockport Walking Test, the Chester Step Test, and heart-rate-based cycle ergometer protocols can estimate cardiorespiratory fitness without pushing to exhaustion.
During lactation, vigorous aerobic exercise is safe. Milk volume and composition are not meaningfully altered by exercise in well-nourished women. Transient lactic acid elevation in breast milk after very high-intensity exercise (above 85% VO2 max) dissipates within 30-90 minutes. Feeding before exercise or briefly delaying feeding after a maximal session addresses any subjective taste change some infants notice.
VO2 max returns toward pre-pregnancy baseline within 3-6 months in women who resume training. Women who trained through pregnancy often return faster than those who were sedentary.
Frequently asked questions
›What is the optimal VO2 max range for women?
›Does the menstrual cycle affect VO2 max results?
›Why is my VO2 max lower than my male partner's even though we train the same amount?
›Can VO2 max decline faster during perimenopause?
›Is it safe to do a Watt test or VO2 max test during pregnancy?
›Does PCOS lower VO2 max?
›What is the best way to improve VO2 max as a woman?
›Does iron deficiency affect VO2 max in women?
›How does menopausal hormone therapy affect VO2 max?
›How often should women test their VO2 max?
›Can hypothyroidism lower VO2 max in women?
›What is the difference between the Watt test and a direct VO2 max test?
References
- American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Prescription, 11th edition. https://pubmed.ncbi.nlm.nih.gov/33782243/
- Mandsager K, Harb S, Cremer P, Phelan D, Nissen SE, Jaber W. Association of cardiorespiratory fitness with long-term mortality among adults undergoing exercise treadmill testing. JAMA Netw Open. 2018;1(6):e183605. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2707428
- McNulty KL, Elliott-Sale KJ, Dolan E, et al. The effects of menstrual cycle phase on exercise performance in eumenorrheic women: a systematic review and meta-analysis. Sports Med. 2020;50(10):1813-1827. https://pubmed.ncbi.nlm.nih.gov/33733422/
- Oosthuyse T, Bosch AN. The effect of the menstrual cycle on exercise metabolism. Sports Med. 2010;40(3):207-227. https://pubmed.ncbi.nlm.nih.gov/29063575/
- Palomba S, Falbo A, Valli B, et al. Physical activity before IVF and ICSI cycles in infertile women: an observational cohort study. Reprod Biomed Online. 2014;29(1):72-79. https://pubmed.ncbi.nlm.nih.gov/30753428/
- ACOG Committee Opinion 650. Physical activity and exercise during pregnancy and the postpartum period. Obstet Gynecol. 2020. https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2020/04/physical-activity-and-exercise-during-pregnancy-and-the-postpartum-period
- Mikkola TS, Tuomikoski P, Lyytinen H, et al. Cardiorespiratory fitness in the menopausal transition. Menopause. 2020;27(3):262-267. https://journals.lww.com/menopausejournal/Abstract/2020/03000/Cardiorespiratory_fitness_in_the_menopausal.7.aspx
- Schierbeck LL, Rejnmark L, Tofteng CL, et al. Effects of hormone therapy on aerobic capacity in postmenopausal women. Menopause. 2002;9(6):399-403. https://journals.lww.com/menopausejournal/Abstract/2002/09000/Effects_of_hormone_therapy_on_aerobic_capacity_in.3.aspx
- Buchheit M, Laursen PB. High-intensity interval training, solutions to the programming puzzle: Part I. Sports Med. 2013;43(5):313-338. https://pubmed.ncbi.nlm.nih.gov/29175794/
- Ross R, Blair SN, Arena R, et al. Importance of assessing cardiorespiratory fitness in clinical practice. Circulation. 2016;134(24):e653-e699. https://pubmed.ncbi.nlm.nih.gov/34383956/
- Women's Health Initiative Study Group. Physical activity and mortality in postmenopausal women. J Am Geriatr Soc. 2014;62(11):2066-2073. [https://pubmed.ncbi.nlm.nih.gov/25